Eduardo Contijoch

Pediatrics resident at @StanfordPedsRes. Formerly of @SinaiMSTP '20 and @Princeton '12. #Microbiome #PediatricianScientist

[Jean-Frederic Colombel @JeanFredericCo1]

New milestone in CD therapy 👍

[Theodore Pak @theodorepak]

Many US hospitals have or will soon stop testing all admitted patients for COVID-19, per recent @SHEA_Epi recs

In this op-ed, Chanu Rhee & Mike Klompas @bwh_id, Julia Koehler @BostonChildrens, and I give seven arguments why testing should continue. 🧵

https://t.co/IeBhxx6rMB

[Michael J Rosen, MD, MSCI @DrRosenIBD]

We have an exceptional opportunity for a senior/mid career faculty scientist to join our @StanfordChild Center for IBD and Celiac Disease as Scientific Director. Visionary and collaborative PhD and/or MDs are eligible to apply. DM w/ ?'s. Pls retweet!👉https://t.co/eS8jnsAaS2

[Eduardo Contijoch @econtijo]

To end on a positive note, let's remember doctors and scientists have been studying and treating influenza for *decades*, and we have years of evidence that shows the efficacy of vaccination, mitigation strategies, and treatment!
#FightFlu

[Eduardo Contijoch @econtijo]

Tis the season!
Even though Halloween is fast-approaching, I'm not only talking about🎃 #SpookySeason🎃... we're creeping up on 🤧#FluSeason 🤧 too!
But how can we get through these scary times? Easy!!!
1) Don't give out pennies to trick-or-treaters, and
2) Get your flu shot!

[Eduardo Contijoch @econtijo]

So let's not sleep on Flu this season -- it's poised to make a comeback.

[Prof. Meghan Azad, PhD @MeghanAzad]

📣 New #ThriveLab paper out in @CellRepMed!

7 years in the making - my first RCT is finally published 🎉🤓

What did we discover? (And why did it take 7 yrs?)
Read on to find out... 🧵

Here’s the #OpenAccess paper https://t.co/faSfZPMszr

#Tweetorial #breastmilk #microbiome

[Cedric C.S. Tan @cedriccstan]

Is there a human blood microbiome? We unpack and address this existing controversy in our latest preprint (https://t.co/atb0nQF4QG). Read on to find out more!

[Bernat Olle 🇺🇦 @bernatolle]

Today we published at @cellhostmicrobe the results of a Phase 1 study of @vedantabio‘s lead candidate VE303 (for C. difficile infection), with a focus one studying pharmacokinetics (PK) and pharmacodynamics (PD) of this defined bacterial consortium. https://t.co/yRu8RQ2Hps🧵 /1

[Tatiana Prowell, MD @tmprowell]

🧵 I’m not sure what I’m about to say has been made clear to ppl w/o a science or #MedTwitter background. It may be a genuine source of confusion (ie good faith questions), so here goes. Many are saying “If #Omicron makes a given person less sick (which appears to be true)…” /1